Regeneron's antibody drug shows protection against COVID-19 for up to 8 months

(Reuters) – Regeneron Pharmaceuticals Inc said on Monday a single dose of its antibody cocktail reduced the risk of contracting COVID-19 by 81.6% in the two to eight months period following the drug’s administration in a late-stage trial. Read full story

Source : https://www.thestar.com.my/news/world/2021/11/08/regeneron039s-antibody-drug-shows-protection-against-covid-19-for-up-to-8-months